Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PaxMedica, Inc.
  6. Summary
    PXMD   US70424C1045

PAXMEDICA, INC.

(PXMD)
 SummaryNewsCompanyFinancials 
Estimated financial data (e) (USD)
Sales 2018 - - -
Net income 2018 -0,22 M - -
Net cash position 2018 0,01 M - -
P/E ratio 2018 -
Yield 2018 -
Sales 2019 - - -
Net income 2019 -0,60 M - -
Net cash position 2019 0,02 M - -
P/E ratio 2019 -
Yield 2019 -
Capitalization 59,1 M 59,1 M -
EV / Sales 2018 -
EV / Sales 2019 -
Nbr of Employees 3
Free-Float 26,3%
More Financials
Company
PaxMedica, Inc. is an early clinical stage biopharmaceutical company. The Company is focused on the development of anti-purinergic therapies (APT) for the treatment of neurodevelopmental disorders, including autism spectrum disorder (ASD) and Fragile X syndrome tremor-ataxia (FXTAS). Its pipeline includes PAX-101 and PAX-102. It is focused on the development and testing of its lead program, PAX-101, an intravenous... 
More about the company
All news about PAXMEDICA, INC.
08/19PaxMedica to Present Data from its Recent Phase 2 Trial of PAX-101 (IV suramin) in Chil..
CI
02/09PaxMedica Announces Positive Results from Phase 2 Trial of PAX-101 (IV suramin) in Chil..
CI
2020PaxMedica, Inc. announced that it has received $3 million in funding
CI
2020PaxMedica, Inc. announced that it expects to receive $3 million in funding
CI
2020PaxMedica, Inc. has filed an IPO in the amount of $18.4575 million.
CI
More news
News in other languages on PAXMEDICA, INC.

- No features available -

More news
Income Statement Evolution
Managers and Directors
Joseph Lucchese Chief Financial Officer
Zachary Rome Chief Operating Officer & Director
Karen A. Dawes Independent Director
Paul Kevin Wotton Independent Director
Robert F. Apple Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PAXMEDICA, INC.0.00%59
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414